The Global Blood Stream Infection Testing Market: 2017-2026 - Set to Record a CAGR of 8.9% - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 18, 2019--The “Blood Stream Infection Testing - Global Market Outlook (2017-2026)” report has been added to ResearchAndMarkets.com’s offering.
According to this report, the Global Blood Stream Infection Testing Market is expected to grow at a CAGR of 8.9% during the forecast period.
Some of the factors such as rise in prevalence of infections such as abdominal infections, dental infections and increase in occurrence geriatric population are fueling the market growth. However, strict government rules associated to the safety and efficacy is limiting the market growth. Blood Stream Infection testing market provides ample opportunities to ongoing R&D activities in various countries across the globe.
Amongst end-user, hospital laboratories segment accounted held significant market share during the forecast period. The healthcare industry is steadily adopting automated solutions to diminish the cost incurred on staffing and to produce accurate results. Also, automated solutions aid healthcare professionals in reducing the time taken for manually intensive tasks. This allows researchers to focus extensively on patient consultation and precision in diagnosis and improving productivity.
By geography, North America dominated the market during the forecast period due to the factors such as high infection rate, increase in awareness, high diagnosis rate, favorable medical reimbursement scenario, and developed medical facilities in this region.
Test Types Covered:Conventional Blood Culture Tests Blood Gases Complete Blood Count (CBC) Culture of Skin Sore Cerebrospinal Fluid (CSF) Culture Platelet Count Urine Culture Chest X-Ray Clotting Studies Polymerase Chain Reaction (PCR) Method Nucleic Acid Testing Mass Spectroscopy Point-of-Care Testing
Products Covered:Reagents Instruments Other Products
Technologies Covered:Non-Conventional Testing Conventional Testing
Applications Covered:Mycobacteria Fungemia Bacteremia
End-users Covered:Hospital Laboratories Reference Laboratories Academic Research Laboratories Independent Diagnostic Centers Other End-users
Companies Profiled:Thermo Fisher Scientific Inc. Siemens Healthcare F. Hoffmann-La Roche AG Danaher Cepheid Inc. C. R. Bard Inc. bioMerieux Inc. Becton, Dickinson & Company Beckman Coulter Inc. Alere Inc. Abbott Laboratories
For more information about this report visit https://www.researchandmarkets.com/research/dbjk9k/the_global_blood?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190118005256/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Infectious Disease Testing
INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/18/2019 09:19 AM/DISC: 01/18/2019 09:19 AM